<DOC>
	<DOCNO>NCT01654380</DOCNO>
	<brief_summary>LY2605541 investigational drug develop treatment diabetes mellitus . This study design understand body handle investigational drug , effect investigational drug body much give . This study also measure much investigational drug get blood stream long take body get rid . The study 2 part : Part A conduct healthy participant . Part B conduct participant type 1 diabetes mellitus ( T1DM ) . This study take approximately 10-14 day spread 6-20 week , include screen . Screening perform within 30 day start study .</brief_summary>
	<brief_title>A Study LY2605541 Versus Insulin Glargine Blood Sugar</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>All Participants Are healthy male participant T1DM Have screen body mass index ( BMI ) 20.029.9 kilogram per square meter ( kg/m^2 ) Healthy Participants ONLY Are overtly healthy , determined medical history physical examination Have fast blood glucose &lt; 108 milligrams/deciliter ( mg/dL ) ( 6.0 millimoles/liter [ mmol/L ] ) screen Participants T1DM ONLY Have diagnosis T1DM least 1 year base medical history Have screening cpeptide &lt; 0.5 nanogram/milliliter ( ng/mL ) Have hemoglobin A1c ( HbA1c ) 6.0 9.0 % screen Have episode severe hypoglycemia past 6 month ( severe hypoglycemia define neurological symptom consistent neuroglycopenia required assistance treatment second party ) All Participants Have hemoglobin level &lt; 12.0 grams/deciliter ( g/dL ) screening Is currently smoker use tobacco product regular basis 6 month prior screen , intend smoke study Healthy Participants ONLY â€¢ Regular use intend use overthe counter prescription medication within 7 14 day , respectively , prior dosing ( apart vitamin/mineral supplement occasional use acetaminophen ibuprofen ) . If situation arises , inclusion otherwise suitable participant may discretion investigator Participants T1DM ONLY Regular use intend use overthecounter prescription medication nutritional supplement affect blood glucose body 's sensitivity insulin promote weight loss within 14 day prior dose Are receive chronic ( lasting longer 14 consecutive day ) systemic inhale glucocorticoid therapy ( exclude topical , intraarticular , intraocular preparation ) receive therapy within 4 week dose Require total daily insulin dose exceed 100 unit ( U ) Have fast triglyceride &gt; 400 mg/dL</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>